DEVICE USER FEE COLLECTION TIED DIRECTLY TO MINIMUM FDA STAFFING LEVELS
This article was originally published in The Gray Sheet
Executive SummaryDEVICE USER FEE COLLECTION TIED DIRECTLY TO MINIMUM FDA STAFFING LEVELS under an amendment to the Medical Device User Fee Act (HR 4728) agreed to July 29 at the House Energy and Commerce/Health Subcommittee mark-up of the bill. The amendment would explicitly bar the agency from collecting device user fees if minimum staffing levels are not maintained.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.